1. Home /
  2. Pharmaceuticals


Here's My Formula for Investing in Gilead Sciences

The stock reached its price target, so now what do the charts say?

Updating Our Amgen Strategy as It Continues to Surge

Here's how to play the stock.

Call This an Off-Label Trade

I've got an option play in Biohaven Pharmaceuticals -- after an earlier trade prior to the Pfizer buyout.

Moderna: What Do the Charts Suggest?

Let's see how things develop.

Aldeyra Therapeutics Is a Speculative Stock Worth a Small Position

Seasoned traders who understand risk could nibble on the long side of ALDX.

We're Adjusting Our Strategy for Neurocrine Biosciences

The shares have taken off and we have new price targets.

You Can Trade Lilly But Don't Act in Haste

One has to think that next year's earnings may get a little wonky.

My Prescription Is to Stand Aside on Pfizer Going Into Earnings

The charts of the big drugmaker present a mixed picture ahead of its third-quarter results.

After AbbVie's Mixed Report, Here's Our Updated Technical Strategy

The shares are now trading above the rising 50-day moving average line and above the rising 200-day moving average line.